why choose us

First received: December 17, 2024

Clinical Trial: A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hyperphosphatemia Patients on Hemodialysis

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Randomized, Placebo-controlled, Double-blind, Phosphate Binder-combination Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Brief Summary: A phase 2, randomized, placebo-controlled, double-blind, phosphate binder-combination study of TS-172 in hyperphosphatemia patients on hemodialysis

Read more